Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years
Andreas Karabis,1 Michelle Mocarski,2 Indra Eijgelshoven,1 Gert Bergman1 1Mapi HEOR and Strategic Market Access, Houten, the Netherlands; 2Forest Research Institute, Jersey City, NJ, USA Purpose: Aclidinium bromide is a long-acting muscarinic antagonistic used in maintenance treatment of chronic o...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-04-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Online Access: | http://www.dovepress.com/economic-evaluation-of-aclidinium-bromide-in-the-management-of-moderat-a16346 |